🔮 OOTWOracle · All predictions · Odds sheet · Track record · Benchmark

Psilocybin for cocaine use disorder will emerge as a named pipeline indication with at least two new IND filings or primary-endpoint trial amendments documented before August 7, 2026.

Predicted 2026-05-09 · Resolves 2026-08-07 · research · Global
18%
ORACLE CONFIDENCE
⏳ Pending
Every outcome is scored publicly in the ledger.

This prediction says the same thing as the previous one but demands it happens within just 90 days (by August 7, 2026). That's an unrealistically tight timeline: preparing an IND application typically takes 6 months on its own. Even if a major trial publishes tomorrow, companies won't have filed two new INDs in three months.

This prediction duplicates the content of the preceding prediction but with a tighter 3-month resolve window (August 7, 2026 — only 90 days from today). Two IND filings in 90 days anchored on a single RCT publication is not consistent with observed industry timelines; IND preparation alone typically requires 3–6 months. The August 2026 resolve date makes this prediction very likely to fail on timing alone, independent of sponsor intent. Confidence sharply reduced. If this prediction cannot be meaningfully differentiated from its December 2026 counterpart, it should be retired; retained here with low confidence to preserve the falsifiable near-term test.

5 new falsifiable predictions, every day at 12:05 PM ET.
Get tomorrow's Oracle →